Company detail

Inscripta

Develops tools for genome-scale engineering and screening.

Company lens

Start with the role, then move into industries, signals, and sources only when needed.

Open industry view

TypePrivateGeographyUnited StatesRoleGenome engineering tooling

What to understand first

Read the company through its industry links

Develops tools for genome-scale engineering and screening.

A compact read before opening the deeper records.

Industries

Synthetic Biology

Capabilities

Programmable cells · DNA synthesis

Signals

Open signal timeline

Sources

Search source trail

Programmable cellsDNA synthesis

Global macro

Inscripta · Market weather around this record

Use this as context, not as a trade instruction.

VIX

19.49

+12.8%

S&P 500

7,415.45

-0.8%

NASDAQ

25,863.94

-1.2%

KOSPI

8,203.84

-1.0%

USD/KRW

1,536.09

+0.3%

DXY

101.29

+0.3%

US 10Y

4.48

+0.7%

Gold

4,156.5

-0.6%

Regime: Risk-awareUpdated: 2026-06-24

Volatility, rates, currency, and broad indexes are background context.
Read company signals together with industry exposure and source evidence.

Primary linkSynthetic Biology Open signal timeline0 Signals Search source trailInscripta